P
Psybio Therapeutics Corp
XTSX:PSYB
Psybio Therapeutics Corp
XTSX:PSYB
Price:
0.01
CAD
Market Cap:
CA$839.3k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Psybio Therapeutics Corp
XTSX:PSYB
|
CA |
|
Forvia SE
PAR:FRVIA
|
FR |
|
L
|
LUSTER LightTech Co Ltd
SSE:688400
|
CN |
|
M
|
Movie Games SA
WSE:MOV
|
PL |
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
CN |
|
Berry Global Group Inc
NYSE:BERY
|
US |
|
Knowledge Economic City Company SJSC
SAU:4310
|
SA |
|
Banco BPM SpA
OTC:BNCZF
|
IT |
|
Moury Construct SA
XBRU:MOUR
|
BE |
|
M
|
M Yochananof and Sons 1988 Ltd
TASE:YHNF
|
IL |
|
N
|
Neuromeka Co Ltd
KOSDAQ:348340
|
KR |
|
Imax Corp
NYSE:IMAX
|
CA |
|
Incap Ltd
BSE:517370
|
IN |
|
P
|
Pegasus International Holdings Ltd
HKEX:676
|
HK |
|
Acasti Pharma Inc
XTSX:ACST
|
CA |
|
Beijing Sojo Electric Co Ltd
SZSE:300444
|
CN |
|
C
|
CNPC Capital Co Ltd
SZSE:000617
|
CN |
|
Incap Oyj
LSE:0ERY
|
FI |
|
GBM Resources Ltd
ASX:GBZ
|
AU |
|
H
|
Hangzhou Robam Appliances Co Ltd
SZSE:002508
|
CN |
|
B
|
ByggPartner Gruppen AB (publ)
STO:BYGGP
|
SE |
|
Boadicea Resources Ltd
ASX:BOA
|
AU |
|
R
|
Rizzo Group AB
STO:RIZZO B
|
SE |
|
New China Life Insurance Company Ltd
SSE:601336
|
CN |
Cash Flow Statement
Cash Flow Statement
Psybio Therapeutics Corp
Psybio Therapeutics Corp
Currency: USD
| Jun-2020 | Sep-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
(0)
|
(0)
|
(3)
|
(6)
|
(9)
|
(11)
|
(10)
|
(8)
|
(6)
|
(5)
|
(4)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
1
|
2
|
3
|
3
|
2
|
2
|
1
|
1
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
(0)
|
(0)
|
1
|
1
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
+10%
|
(1)
-3 058%
|
(3)
-351%
|
(5)
-50%
|
(7)
-47%
|
(8)
-8%
|
(6)
+15%
|
(5)
+14%
|
(3)
+37%
|
(3)
+26%
|
|
| Investing Cash Flow | ||||||||||||
| Other Items |
0
|
0
|
0
|
(7)
|
(6)
|
(4)
|
(2)
|
6
|
6
|
4
|
2
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
(7)
N/A
|
(6)
+24%
|
(4)
+36%
|
(2)
+31%
|
6
N/A
|
6
-14%
|
4
-36%
|
2
-37%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
11
|
11
|
11
|
11
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash from Financing Activities |
0
N/A
|
0
N/A
|
11
N/A
|
11
N/A
|
11
N/A
|
10
-2%
|
(0)
N/A
|
(0)
-55%
|
(0)
-8%
|
(0)
+85%
|
0
N/A
|
|
| Change in Cash | ||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Net Change in Cash |
(0)
N/A
|
(0)
+10%
|
10
N/A
|
0
-99%
|
0
+166%
|
(0)
N/A
|
(10)
-6 914%
|
(0)
+97%
|
(0)
-9%
|
0
N/A
|
(0)
N/A
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
(0)
N/A
|
(0)
+10%
|
(1)
-3 058%
|
(3)
-351%
|
(5)
-50%
|
(7)
-47%
|
(8)
-8%
|
(6)
+15%
|
(5)
+14%
|
(3)
+37%
|
(3)
+26%
|
|
Switch to:
Switch to:
See Also
Discover More
